Literature DB >> 23912248

Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage.

Hyo Keun Jeon1, Moon Young Kim, Soon Koo Baik, Hong Jun Park, Hoon Choi, So Yeon Park, Bo Ra Kim, Jin Heon Hong, Ki Won Jo, Seung Yong Shin, Jung Min Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Dong Joon Kim, Ki Tae Suk, Gab Jin Cheon, Young Don Kim, Dae Hee Choi, Sung Joon Lee.   

Abstract

BACKGROUND AND AIM: The clinical impact and complications of hepatogenous diabetes (HD) on cirrhosis have not been elucidated. This study aimed to evaluate the relationship of HD with portal hypertension (PHT) and variceal hemorrhage and to assess the prevalence of HD.
METHODS: From July 2007 to December 2009, 75-g oral glucose tolerance test and insulin resistance (IR) were evaluated for 195 consecutive cirrhotic liver patients (M:F = 164:1, 53.0 ± 10.2 years) who had no history of diabetes mellitus. IR was calculated using the homeostasis model of assessment-insulin resistance (HOMA-IR) formula. Endoscopy for varices, hepatic venous pressure gradient (HVPG), and serologic tests were also conducted.
RESULTS: HD was observed in 55.4 % (108/194) of the patients. Among them, 62.0 % required OGTT for diagnosis because they did not show an abnormal fasting plasma glucose level. The presence of HD showed a significant correlation with high Child-Pugh's score, variceal hemorrhage, and HVPG (p = 0.004, 0.002, and 0.019, respectively). In multivariate analysis, Child-Pugh's score (OR 1.43, 95 % CI 1.005-2.038) and HVPG (OR 1.15, 95 % CI 1.003-2.547) had significant relationships with HD. Patients with recent variceal hemorrhages (within 6 months) exhibited significantly higher glucose levels at 120 min in OGTT compared to patients without hemorrhages (p = 0.042). However, there was no difference in fasting glucose levels. The 120-min glucose level and HOMA-IR score were significantly and linearly correlated with HVPG (r (2) = 0.189, p < 0.001 and r (2) = 0.033, p = 0.011, respectively).
CONCLUSION: HD and IR have significant relationships with PHT and variceal hemorrhage. Postprandial hyperglycemia in particular had a significant relationship with variceal hemorrhage.

Entities:  

Mesh:

Year:  2013        PMID: 23912248     DOI: 10.1007/s10620-013-2802-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

2.  Mechanism of insulin resistance associated with liver cirrhosis.

Authors:  M J Müller; O Willmann; A Rieger; A Fenk; O Selberg; H U Lautz; M Bürger; H J Balks; A von zur Mühlen; F W Schmidt
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

4.  Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.

Authors:  Tsutomu Nishida; Shingo Tsuji; Masahiko Tsujii; Shoko Arimitsu; Yoshimichi Haruna; Eiichi Imano; Masaaki Suzuki; Tsutomu Kanda; Sunao Kawano; Naoki Hiramatsu; Norio Hayashi; Masatsugu Hori
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

5.  Hepatic reticuloendothelial protection against bacteremia in experimental hemorrhagic shock.

Authors:  B J Pardy; R C Spencer; H A Dudley
Journal:  Surgery       Date:  1977-02       Impact factor: 3.982

6.  Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

Authors:  Y T Kruszynska; D S Harry; R N Bergman; N McIntyre
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

7.  Prognostic significance of diabetes in patients with cirrhosis.

Authors:  G Bianchi; G Marchesini; M Zoli; E Bugianesi; A Fabbri; E Pisi
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

Review 8.  Vascular endothelial dysfunction in cirrhosis.

Authors:  Yasuko Iwakiri; Roberto J Groszmann
Journal:  J Hepatol       Date:  2007-03-05       Impact factor: 25.083

9.  Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock.

Authors:  W T Sorell; E M Quigley; G Jin; T J Johnson; L F Rikkers
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways.

Authors:  G Svegliati-Baroni; F Ridolfi; A Di Sario; A Casini; L Marucci; G Gaggiotti; P Orlandoni; G Macarri; L Perego; A Benedetti; F Folli
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

View more
  14 in total

1.  Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats.

Authors:  Li-Rui Tang; Yan-Yan Tao; Cheng-Hai Liu; Hai-Nan Wang
Journal:  Chin J Integr Med       Date:  2017-12-05       Impact factor: 1.978

Review 2.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 3.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

4.  Hepatogenous Diabetes - A Report from Central India.

Authors:  Praveen Vasepalli; Mohd T Noor; Bhagwan S Thakur
Journal:  J Clin Exp Hepatol       Date:  2021-08-25

5.  Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor Jesús Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

6.  Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.

Authors:  Chia-Chi Lung; Zhi-Hong Jian; Jing-Yang Huang; Oswald Ndi Nfor
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

7.  Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

Review 8.  Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test.

Authors:  Tsutomu Nishida
Journal:  J Endocr Soc       Date:  2017-05-23

9.  Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?

Authors:  Thazhath Mavali Ramachandran; Aninchent Harayil Rajan Rajneesh; George Sarin Zacharia; Rajendran P Adarsh
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  The prevalence and association of chronic kidney disease and diabetes in liver cirrhosis using different estimated glomerular filtration rate equation.

Authors:  Cheng-Yi Chen; Cheng-Jui Lin; Chih-Sheng Lin; Fang-Ju Sun; Chi-Feng Pan; Han-Hsiang Chen; Chih-Jen Wu
Journal:  Oncotarget       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.